UPDATED Aug 17, 2025
Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
690 | HK$0.14 | -3.3% | 158.9% | HK$865.8m | n/a | PE10.5x | n/a | 1.9% | ||
2511 | HK$3.32 | 3.4% | 118.4% | HK$1.9b | n/a | PB4.1x | n/a | n/a | ||
9966 | HK$9.00 | -1.1% | 254.3% | HK$8.7b | HK$7.22 | PE48.2x | n/a | n/a | ||
8225 | HK$0.18 | 5.3% | 92.5% | HK$178.2m | n/a | PS6.2x | n/a | n/a | ||
455 | HK$0.19 | 10.6% | -14.5% | HK$404.2m | n/a | PS1.2x | n/a | 0% | ||
2898 | HK$6.90 | -5.2% | 7.3% | HK$1.0b | n/a | PS25104x | n/a | n/a | ||
8329 | HK$0.16 | -0.6% | 10.3% | HK$268.5m | n/a | PE9.8x | n/a | 3.3% | ||
8247 | HK$0.95 | 11.8% | 61.0% | HK$137.5m | n/a | PB0.8x | n/a | 0% | ||
9887 | HK$69.35 | 4.3% | n/a | HK$13.4b | n/a | PB63.9x | n/a | n/a | ||
1875 | HK$2.36 | -0.4% | 30.4% | HK$1.8b | n/a | PE230.5x | n/a | n/a | ||
6998 | HK$3.73 | 3.6% | 186.9% | HK$1.9b | n/a | PS8.7x | n/a | n/a | ||
1652 | HK$0.35 | 9.2% | -62.2% | HK$262.5m | n/a | PB0.7x | n/a | 0% | ||
950 | HK$2.15 | 25.0% | 82.2% | HK$1.3b | n/a | PE13.6x | n/a | 2.3% | ||
2509 | HK$22.46 | 8.5% | -6.4% | HK$5.0b | n/a | PS14.3x | n/a | n/a | ||
2627 | HK$47.18 | n/a | n/a | HK$18.6b | n/a | PS65.6x | n/a | n/a | ||
2181 | HK$0.74 | 27.6% | 102.7% | HK$3.1b | n/a | PS10.8x | n/a | n/a | ||
858 | HK$0.13 | 7.5% | 258.3% | HK$308.3m | n/a | PE1.4x | n/a | n/a | ||
2315 | HK$24.64 | -2.5% | 296.1% | HK$9.8b | n/a | PE269.2x | n/a | n/a |